Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-06

Clinical Trial Update: Costimulatory Molecules as Biomarkers in Cystic Fibrosis

View source ↗

Summary

A clinical trial evaluating costimulatory molecules as biomarkers in cystic fibrosis has completed under the sponsorship of Oregon Health and Science University…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Oregon Health and Science University | Conditions: Cystic Fibrosis | Status: COMPLETED